Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Subhasree Kar

MYSTERIOUS: Is johnson johnson stock outperforming the s p 500 - You Need To See This

Johnson & Johnson (JNJ) is a global healthcare conglomerate, renowned for its broad presence in pharmaceuticals and medical devices. Headquartered in New Brunswick, New Jersey, its market cap is around $500.1 billion. Johnson & Johnson has evolved into one of the world’s largest and most diversified healthcare firms, with a global workforce and a portfolio spanning cutting-edge therapeutics, medical technologies, and historically, consumer health brands.

Companies worth $200 billion or more are generally described as “mega-cap stocks,” and JNJ definitely fits that description, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the drug manufacturers industry.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.